Prophylactic effect of topical betaxolol and dorzolamide on the fellow eye in unilateral canine primary angle closure glaucoma: 60 cases (2016.1-2021.5)
Open Access
- 30 September 2022
- journal article
- research article
- Published by The Korean Society of Veterinary Science (KJVR) in Korean Journal of Veterinary Research
- Vol. 62 (3) , e26
Abstract
This study was aimed to evaluate the prophylactic anti-glaucoma effect of topical 5% betaxolol (BTX) and 2% dorzolamide (DRZ) on the second eye in dogs with unilateral primary angle closure glaucoma (PACG). Medical records of 60 dogs with unilateral PACG who received prophylactic anti-glaucoma eyedrops in the second eye, from 2016 to 2021, were reviewed. The duration of prophylactic effects of BTX only and DRZ after BTX failure was calculated. The prophylactic effects of BTX were maintained on 28/60 (46.7%) eyes until last visit and BTX failure was observed on median 510 (range, 53-1,927) days in 32/60 (53.3%) eyes. After DRZ instillation in BTX failure eyes, the prophylactic effects were extended at median 610 (range, 157-2,270) days in 21/32 (65.6%) eyes. DRZ failure eyes (17/21, 81.0%) eyes required chemical ablation or surgical intervention due to uncontrolled intraocular pressure. The duration of prophylactic effects was decreased with aging (R² = 0.334, p = 0.006). The predominant breeds were Shih-Tzu (41.9%) and American Cocker Spaniel (30.6%) with no significant differences in survival curves (p = 0.210). The average prophylactic effects of BTX persisted more than 1.5 year and could be selected the first prophylactic eye drop in unilateral PACG. Also, early surgical intervention should be considered in prophylactic medications failure cases.Keywords
Funding Information
- BK21 FOUR Future Veterinary Medicine Leading Education and Research Center and the Research Institute for Veterinary Science
- National Research Foundation of Korea ((2021R1I1A1A01058695)
This publication has 21 references indexed in Scilit:
- Efficacy of prophylactic antiglaucoma and anti‐inflammatory medications in canine primary angle‐closure glaucoma: a multicenter retrospective study (2004–2012)Veterinary Ophthalmology, 2013
- Long-term evaluation of the use of Ahmed gonioimplants in dogs with primary glaucoma: nine cases (2000–2008)Journal of the American Veterinary Medical Association, 2011
- Functional and Structural Changes in a Canine Model of Hereditary Primary Angle-Closure GlaucomaInvestigative Ophthalmology & Visual Science, 2010
- Effect of topical 0.5% betaxolol administration on intraocular pressure in clinically normal dogsComparative Clinical Pathology, 2009
- Retrograde axonal transport obstruction of brain‐derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucomaVeterinary Ophthalmology, 2007
- Microvessel loss, vascular damage and glutamate redistribution in the retinas of dogs with primary glaucomaVeterinary Ophthalmology, 2007
- Canine keratoconjunctivitis sicca: disease trends in a review of 229 casesJournal of Small Animal Practice, 2006
- Canine goniodysgenesis‐related glaucoma: a morphologic review of 100 cases looking at inflammation and pigment dispersionVeterinary Ophthalmology, 2005
- Prevalence of the breed‐related glaucomas in pure‐bred dogs in North AmericaVeterinary Ophthalmology, 2004
- The efficacy of topical prophylactic antiglaucoma therapy in primary closed angle glaucoma in dogs: a multicenter clinical trialJournal of the American Animal Hospital Association, 2000